You Bought Defense Stocks Because There's a War. That's Not a Strategy.

Open your Zerodha or Groww portfolio right now. Count how many defense stocks you added since February 28, the day the Iran war began.

One? Two? Five?

Now check what percentage of your total equity portfolio sits in defense and aerospace. If you started the year with zero defense exposure and now hold 15-25% in BEL, HAL, Bharat Dynamics, and Mazagon Dock, you did not make five separate investment decisions. You made one decision, repeated five times. Not "this company has strong fundamentals at a reasonable valuation." Just "there is a war."

That is narrative bias operating in real time, on real money, in your real portfolio.

What happened to defense stocks since February 28?

On February 28, 2026, US strikes against Iran escalated into open conflict. Within days, Indian defense stocks started climbing. BEL jumped from ₹354 to above ₹418 by early April, a gain of roughly 18%. HAL moved from ₹3,480 to ₹3,670, up about 5.5%. Bharat Dynamics surged over 9% in a single session after the DAC cleared ₹2.38 lakh crore in acquisitions.

India's Defence Acquisition Council approved capital acquisitions worth ₹2.38 lakh crore in early April 2026. Real number. Real orders. Real revenue potential.

But here is the question nobody on your WhatsApp group is asking: how much of that ₹2.38 lakh crore is already priced into a 52x P/E multiple?

Nifty Defence Index trades at approximately 52 times trailing earnings. Nifty 50 sits at roughly 20x. You are paying 2.6 times the market average to own defense stocks. For that premium to be justified, defense companies need to grow earnings at 25-30% annually for the next three to four years, consistently, without execution delays, without budget cuts, without the conflict ending.

Already, the conflict shows signs of de-escalation. Iran agreed to a two-week ceasefire on April 7. It collapsed within 48 hours, yes. But the fact that both sides sat at the table tells you the trajectory. Wars end. Narratives expire. Multiples compress.

Why does "war = defense stocks" feel like a genius trade?

Because the logic is seductive in its simplicity. War means higher defense spending. Higher defense spending means more orders for BEL, HAL, Mazagon Dock. More orders means higher revenue. Higher revenue means the stock goes up.

Every step in that chain is individually plausible. The chain as a whole is dangerously incomplete.

Here is what the narrative skips:

Pricing. Stock markets are not queues where you wait for good news and then buy. Defense stocks started rallying on February 28. By the time "should I buy defense stocks" trended on Google, the easy money was already made. The DAC approval, the budget increase, the geopolitical premium: they are all reflected in the price you paid today. You are not buying the news. You are buying after everyone else already did.

Valuation matters more than narrative. BEL at 38-42x P/E was a ₹250 stock in 2023. It is a ₹418 stock today. Earnings have grown, yes. But multiples expanded faster than earnings. You are paying for future growth that must materialize at high rates for years. If defense spending plateaus, or if orders take 3-5 years to convert to revenue (which is normal for defense procurement), the stock does not need bad news to fall. It just needs the growth to be slower than what 42x expects.

Concentration kills. This is the core problem. You did not buy one defense stock as a small allocation. Your portfolio data, if you checked it honestly, shows you tilted heavily into a single sector based on a single thesis. When that thesis weakens, your entire portfolio weakens with it.

What does your trade history actually reveal?

Pull up your Zerodha or Groww transaction log for March 2026. Filter by sector.

If you see a cluster of defense stock purchases between March 1 and March 20, all bought within days of each other, all in the same sector, you did not conduct five rounds of independent research. You read one WhatsApp forward, saw one YouTube thumbnail, heard one friend mention HAL, and then bought everything that matched the story.

This is how narrative fallacy works in Indian markets. One simple, compelling story ("war = defense stocks go up") replaces rigorous analysis. It spreads through social networks, each retelling adding confidence without adding information. By the time you act on it, you are the last buyer in a chain of buyers, all holding the same thesis, all concentrated in the same sector.

PortoAI's behavioral fingerprint tracks exactly this pattern. When your buy orders cluster in a single sector within a short timeframe, and those purchases coincide with a trending news narrative, the system flags it as a narrative-driven concentration risk. Not because defense stocks are bad companies. Because buying five companies in the same sector for the same reason is not diversification. It is a concentrated bet disguised as a portfolio.

Did defense stocks protect you during the March crash?

This is the argument you tell yourself: "Defense stocks are a hedge. When Nifty falls because of the war, defense stocks go up. So I am protected."

Partially true. During the worst of the March selloff, when Nifty dropped from 22,500 to below 20,400, defense stocks held up better than the broader market. BEL fell less than Nifty. HAL outperformed. This made defense exposure feel like genius positioning.

Now look at April 9. Sensex dropped 931 points, snapping a five-day winning streak. Brent crude jumped back above $97 as Iran accused the US of ceasefire violations. The war is not over. Defense stocks should rally, right?

BEL gained 1.6% on April 9. Not bad, but not the 5-10% surges retail investors expect from a "war hedge" on a day the broad market crashes. Correlation between war headlines and defense stock returns is weaker than the narrative suggests. Defense companies earn revenue from long-term government contracts with 3-7 year execution cycles. A 48-hour ceasefire collapse does not change their order book. A 48-hour ceasefire collapse also does not change their earnings. The stock moves on sentiment, not on revenue changes, and sentiment is the most unreliable driver you can bet your portfolio on.

What happens to defense stocks when wars end?

History is clear, even if uncomfortable.

After the Kargil war ended in July 1999, the broad market rallied 49% in the following months. Defense stocks like BEL saw short-term boosts during the conflict, but the rally faded once the war narrative left the headlines. Longer-term returns were driven by actual order execution and budget follow-through, not by the conflict itself.

Across geopolitical events, the pattern is consistent. Defense stocks rally on narrative. They correct when narrative fades. Stocks that sustain returns are ones with genuine order book growth and execution capability, not the ones retail investors bought because of a WhatsApp forward.

For the current Iran war cycle, consider the scenarios:

Ceasefire becomes permanent. Brent crude drops below $85. The war premium evaporates. Defense stocks lose the narrative driver. The Nifty Defence Index P/E compresses from 52x to 35-40x. On a stock trading at ₹400, that is a 20-30% drawdown from multiple compression alone, even if earnings stay flat.

War drags on but stabilizes. Oil stays at $95-100. Markets adapt. The "war" headline becomes old news. Defense stocks stop rallying on each escalation because the escalation is no longer novel. Sideways price action at elevated valuations, where your return is determined entirely by earnings delivery over 2-3 years.

War escalates dramatically. Broad market crashes 15-20%. Defense stocks hold up relatively, but your overall portfolio is down because you concentrated 25% in one sector and left 75% exposed to the broader selloff. The hedge was not as effective as you imagined because you still owned banks, IT, and consumer stocks.

None of these scenarios reward the person who bought defense stocks at 52x because of a war.

How is this different from buying pharma during COVID?

Exactly the same behavioral pattern. Different sector, same mistake.

In March 2020, Indian retail investors piled into pharma stocks because "pandemic = pharma goes up." Dr. Reddy's, Sun Pharma, Cipla, and Divi's Labs all surged. The Nifty Pharma index rallied over 50% from March to August 2020.

Early buyers, before the narrative became consensus, did well. Investors who bought in June-July 2020 when "buy pharma" was the WhatsApp consensus got in at the top. Nifty Pharma then underperformed Nifty 50 for the next two years.

Investors who concentrated their portfolios based on a single story ended up owning a sector at peak valuation with declining narrative support. Trade worked until it did not. Exit was always the problem.

Defense stocks in April 2026 are pharma stocks in June 2020. The early movers made money. You are not the early mover. You are the consensus buyer, arriving after the stock is up 20%, paying 52x earnings, holding a thesis that depends on a war continuing.

Ask yourself: are you genuinely bullish on India's defense manufacturing capabilities over a 5-year horizon? Or did you buy BEL last week because of a headline?

If the answer is the headline, your trade has an expiration date. You just do not know what it is.

What should you actually do with your defense exposure?

Do not panic-sell everything you bought. That compounds the behavioral mistake with transaction costs. But do three things this week:

First, measure your actual sector concentration. Open PortoAI or manually calculate what percentage of your equity portfolio sits in defense and aerospace. If it is above 10-15% and you did not hold defense stocks before February 2026, you have a narrative-driven concentration problem. PortoAI's sector concentration analysis shows this in one screen across your Zerodha and Groww accounts.

Second, separate the thesis from the narrative. If you believe India's defense budget will grow 10-15% annually for five years, and BEL's order book of ₹76,000+ crore will convert to revenue at 15-20% annual growth, that is a fundamental thesis. Price it. Check if the current valuation supports that growth. If HAL at 40x earnings requires 25% annual earnings growth, and HAL's actual revenue growth has been 12-15%, the math does not work.

Third, set an exit rule before you need it. Decide now: at what price or event will you sell? If the ceasefire becomes permanent and oil drops to $80, will you still hold defense stocks at 52x? If you cannot answer that question, you do not have a position. You have a hope.

PortoAI's overtrading detection also tracks whether your trading frequency spiked during the war period. If you made more trades in March 2026 than in any previous month, the war did not give you better ideas. It gave you more anxiety, and anxiety turned into activity.

Will the DAC's ₹2.38 lakh crore order actually reach these companies?

The Defence Acquisition Council cleared ₹2.38 lakh crore in capital acquisitions in early April. Headlines screamed "mega defense spend." Stock prices jumped 5-10% in a session.

Reality: DAC approval is the first step in a procurement chain that takes 3-7 years to complete. Approval to acquisition to manufacturing to delivery to revenue recognition. India's defense procurement system has historically taken 7-10 years from approval to delivery. The Rs 6.7 lakh crore in project approvals during FY26 will trickle into company order books over years, not quarters.

For the stock market, the entire ₹2.38 lakh crore is priced in on Day 1. Revenue arrives over Year 3 to Year 7. If you bought the stock on the DAC approval headline, your returns over the next 12 months depend not on the order but on the next headline.

That is the core problem with narrative trading. Price moves on story. Value moves on execution. Between those two, retail investors lose money.

Your portfolio is a record of your decisions. Not the decisions you think you made (careful research, fundamental analysis, long-term conviction) but the decisions you actually made (saw a war headline, bought five defense stocks in one week, concentrated 20% of your portfolio into a single sector at historically high valuations).

PortoAI reads that record. It connects to your Zerodha or Groww account, maps your trades against market events, and shows you the pattern you cannot see from inside the trade. No judgement. Just measurement. And what it measures, for most Indian investors during this war, is a portfolio that went from diversified to dangerously concentrated in six weeks.

The war will end. The narrative will fade. Your sector concentration will not fix itself.

Check it today.

Frequently Asked Questions

Should I buy defense stocks during the Iran war in 2026?

Buying defense stocks solely because a war is happening is a narrative trade, not an investment thesis. The Nifty Defence Index trades at approximately 52x trailing earnings as of April 2026, far above the Nifty 50 P/E of 20x. BEL, HAL, and Bharat Dynamics rallied 15-28% during March-April 2026, but this rally is driven by headline-chasing, not improved fundamentals. Historical data shows defense stock rallies during conflicts fade when peace talks begin. If the Iran ceasefire holds or oil drops, these stocks lose their primary narrative driver while retaining peak valuations.

What is the P/E ratio of Indian defense stocks in April 2026?

The Nifty Defence Index trades at a P/E ratio of approximately 52x as of April 2026. Individual defense stocks trade at varied multiples: Bharat Dynamics above 70x, HAL at roughly 35-40x, and BEL at around 38-42x. The Nifty 50 trades at approximately 20x and the Nifty Midcap 150 at about 28x. Defense stocks are priced for perfection, meaning any execution miss, order delay, or geopolitical de-escalation could trigger a sharp correction from these elevated levels.

Did defense stocks fall after the Kargil war ended in 1999?

After the Kargil war ended in July 1999, the broad Indian market rallied 49% in the following months. Defense stocks like BEL saw short-term boosts during the conflict, but the rally faded once the war narrative dissipated. Longer-term returns of defense companies were driven by actual order flows and budget allocations, not by the conflict itself. The pattern is consistent: narrative-driven rallies do not sustain without fundamental backing.

How does narrative bias affect stock picking in India?

Narrative bias is the tendency to construct a simple story and treat it as an investment thesis. In Indian markets, this manifests as retail investors piling into sectors based on headlines: defense during wars, pharma during pandemics, and IT during rupee depreciation. By the time the narrative reaches WhatsApp groups and YouTube channels, the price already reflects the story. You end up buying at peak pricing and holding until the next headline replaces yours. PortoAI's behavioral fingerprint tracks whether your buy orders cluster around trending news events, which is a reliable indicator of narrative-driven trading.

What does PortoAI detect about sector concentration during crises?

PortoAI's sector concentration analysis connects to your Zerodha or Groww account and calculates your actual sector exposure weighted by current market value. During the Iran war, many retail portfolios show defense and oil sector weights jumping from 5-10% to 25-35% of total equity, a dangerous concentration built on a single geopolitical thesis. The system flags when any sector crosses your historical allocation range and shows you the timeline of how your concentration changed, helping you see the pattern of narrative-driven buying before it becomes a portfolio-level risk.

Is there a difference between buying defense stocks for war vs long-term growth?

The difference is in the thesis and the timeline. A long-term investor buying HAL at a reasonable valuation because India's defense budget is growing 10-15% annually and HAL's order book exceeds ₹1.5 lakh crore has a fundamental thesis. A retail investor buying HAL at 40x earnings because there is a war has a narrative. The fundamental investor has a price target, an exit plan, and acceptance that execution risk exists. The narrative buyer has no exit plan beyond "the war continues." When the war ends, the fundamental investor re-evaluates. The narrative buyer panics.